Maine Statutes
§ 22 §2673 — Action against health care practitioner or health care provider license prohibited
Maine·Title 22 HEALTH AND WELFARE·Part 5 FOODS AND DRUGS·Ch. 602-A ACCESS TO INVESTIGATIONAL TREATMENTS FOR TERMINALLY ILL PATIENTS
A licensing board may not revoke, refuse to renew or suspend the license of or take any action against a health care practitioner as defined in Title 24, section 2502, subsection 1-A based solely on the health care practitioner's recommendations to an eligible patient regarding access to or treatment with an investigational drug, biological product or device, as long as the recommendations are consistent with medical standards of care.
The licensing agency may not revoke, refuse to renew or suspend the license of or take any action against a health care provider as defined in Title 24, section 2502, subsection 2 based solely on the health care provider’s involvement in the care of an eligible patient using an investigational drug, biological product or device.
Free access — add to your briefcase to read the full text and ask questions with AI
Maine § 22 §2673 (Action against health care practitioner or health care provider license prohibited) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Legislative History
PL 2015, c. 418, §1 (NEW).
Nearby Sections
15
§ 22 §260
Maine Health Access Fund§ 22 §2601
Definitions§ 22 §2601-A
Scope§ 22 §2602
Fees for testing§ 22 §2602-A
Fees for testing private water supplies§ 22 §2603
Shipping costs§ 22 §2604-A
Roadside springs§ 22 §2605
Administration§ 22 §2606
Emergency planning§ 22 §2607
Approved laboratories§ 22 §2609
Recovery of testing costs